BackSCIENCE_HEALTH
India’s antibiotic crisis has a vaccine solution
The piece argues that antibiotic resistance in India is a mounting public health crisis and highlights vaccination as a key strategy to reduce antibiotic use and resistance. It traces past vaccination successes, current gaps, and studies showing vaccines’ potential to curb infections driving antibiotic demand.
Why It Matters
Vaccines could prevent infections that drive antibiotic use, slowing the emergence of resistance. With India bearing a large share of the AMR burden, a vaccine-focused approach could yield substantial health and economic benefits.
Timeline
8 Events
Vaccination trajectory and policy implications
2014-2026
India’s vaccination story over the last decade has included genuine achievement followed by frustrating stagnation; the piece argues that vaccination should be treated as a core national strategy to tackle antibiotic resistance, leveraging India’s manufacturing base, cold chain, and immunisation workforce.
Typhoid incidence and resistance surveillance (2017–2020)
2017-2020
Active surveillance between 2017 and 2020 found typhoid incidence as high as 1,173 cases per 100,000 child-years in Vellore, 714 in Kolkata, and 576 in Delhi; carbapenem-resistant Salmonella typhi strains have already been detected in India.
Carbapenem-resistant Salmonella typhi detected (reported)
May 7, 2026
The article notes that carbapenem-resistant Salmonella typhi strains have been detected in India.
GARP report on vaccination to tackle AMR released in New Delhi
May 7, 2026
A report released this week in New Delhi by the Global Antibiotic Resistance Partnership (GARP), in collaboration with Christian Medical College Vellore and a national working group of infectious disease specialists, microbiologists, and public health experts, argues that optimal use of vaccines against priority bacterial pathogens could avert up to 2.5 billion defined daily doses of antibiotics annually (about 22% of global consumption). It notes that India bears the largest share of the global AMR burden and has done the least to exploit vaccination to address resistance.
Influenza vaccination reduces antibiotic use (2023 study)
2023
A 2023 study found that influenza vaccination reduces the proportion of people receiving antibiotics by roughly 37%; in India, where laboratory confirmation of influenza is often unavailable at the point of care, many patients with influenza-like illness receive empirical antibiotics.
AMR deaths in India (2021)
2021
World Health Organization and the University of Washington estimate drug-resistant infections caused 267,000 direct deaths in India in 2021, with nearly a million more associated.
PCV introduced into childhood immunisation
2017
India introduced the pneumococcal conjugate vaccine (PCV) into childhood immunisation in 2017; a study by the One Health Trust found a measurable decline in antibiotic consumption three to four years after PCV introduction in the private sector, suggesting similar effects could be achieved in the public sector for adults and high-risk groups.
Mission Indradhanush launched
December 2014
Mission Indradhanush was launched in December 2014 with the target of reaching 90% full immunisation coverage through systematic catch-up campaigns.